Impact of renin-angiotensin system inhibitors on outcomes after transcatheter aortic valve replacement: A meta-analysis.
Yinghao SunJie LiGuang LiRuixin FanJianFang LuoPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
RAS inhibitors were associated with lower midterm all-cause mortality after TAVR.